Salih Ehsan/LinkedIn
Nov 21, 2026, 12:06
Salih Ehsan: Why Iron Therapy May Not Work
Salih Ehsan, Chief Executive Officer at Kulsoom Society of Hematology, shared a post on LinkedIn:
“Around 20 to 30 % population ( % depends on age , gender, ethnicity, socioeconomic conditions) around the globe is poor or non responder to oral iron.
To proceed forward fallowing ‘Ds’ need to be considered dieat, dose, duration, drugs, diseases underlying ( responsible for malabsorption, chronic blood loss) , diagnosis pitfall ( thalassemia trait, NTDTs, TDTs, ACD, IRIDA, mixed anemia, sidroblastic anemias).”

See more in the gallery.
Other posts featuring Salih Ehsan on Hemostasis Today.
-
Nov 21, 2026, 11:59Edward Lee Carter: DOACs vs Warfarin for LV Thrombus – Are We Getting Closer to an Answer?
-
Nov 21, 2026, 11:50Abdul Mannan: When G6PD Testing Misleads During Acute Hemolysis
-
Nov 21, 2026, 11:36Emma Copperwaite: Transforming the Transfusion Pathway Through Digital Innovation
-
Nov 21, 2026, 11:28Nathan Connell: Rethinking the Role of Factor V in Hemostasis
-
Nov 21, 2026, 11:16Jecko Thachil: Optimizing Corticosteroid Therapy in ITP
-
Nov 21, 2026, 08:36Sangwan Sim: ASH 2026 to Highlight Research into PU.1-Related Neutrophil Dysfunction
-
Nov 21, 2026, 08:29Liz Tate: First Percutaneous LAAO Procedure Performed at The Park Hospital for Stroke Prevention
-
Nov 21, 2026, 08:26Robert Sidonio: WFH Webinar to Address Key Challenges in Rare Bleeding Disorders Care
-
Nov 21, 2026, 08:21Jenni Majumdar: What Changing Blood Transfusion Guidelines Mean for Patients and Surgical Teams